| Dr Milton C Wong, MD | |
|
12301 Snow Rd, Parma, OH 44130-1002 | |
| (216) 362-2185 | |
| Not Available |
| Full Name | Dr Milton C Wong |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 40 Years |
| Location | 12301 Snow Rd, Parma, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073548269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35-073827 (Ohio) | Primary |
| 207R00000X | Internal Medicine | 173905 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Health | Concord, OH | Hospital |
| Akron General Medical Center | Akron, OH | Hospital |
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Hospitalist Llc | 5496648123 | 56 |
News Archive
The first large-scale, multi-hospital evaluation of an "all or none" federal policy intended to improve outcomes in sepsis patients finds that the guidelines are a wash-;on average they neither helped nor hurt despite significant investments in their implementation, according to an analysis by University of Pittsburgh School of Medicine clinician-scientists of nearly a dozen hospitals in one academic health system.
A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells.
Pioneering technology by scientists at Queen's University Belfast, which is transforming the lives of millions of people in Asia, is now being used to create safer drinking water in the United States.
Pediatric researchers who tested newborn animals with an existing human drug used in adults with diabetes report that this drug, when given very early in life, prevents diabetes from developing in adult animals. If this finding can be repeated in humans, it may become a way to prevent at-risk infants from developing type 2 diabetes.
While cardiovascular disease (CVD) remains the leading cause of death globally, new research led by NYU Grossman School of Medicine and Moi University School of Medicine (Kenya) found that addressing and incorporating social determinants of health (such as poverty and social isolation) in the clinical management of blood pressure in Kenya can improve outcomes for patients with diabetes or hypertension.
› Verified 8 days ago
| Entity Name | North East Ohio Group Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063575462 PECOS PAC ID: 8426960618 Enrollment ID: O20031105000352 |
News Archive
The first large-scale, multi-hospital evaluation of an "all or none" federal policy intended to improve outcomes in sepsis patients finds that the guidelines are a wash-;on average they neither helped nor hurt despite significant investments in their implementation, according to an analysis by University of Pittsburgh School of Medicine clinician-scientists of nearly a dozen hospitals in one academic health system.
A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells.
Pioneering technology by scientists at Queen's University Belfast, which is transforming the lives of millions of people in Asia, is now being used to create safer drinking water in the United States.
Pediatric researchers who tested newborn animals with an existing human drug used in adults with diabetes report that this drug, when given very early in life, prevents diabetes from developing in adult animals. If this finding can be repeated in humans, it may become a way to prevent at-risk infants from developing type 2 diabetes.
While cardiovascular disease (CVD) remains the leading cause of death globally, new research led by NYU Grossman School of Medicine and Moi University School of Medicine (Kenya) found that addressing and incorporating social determinants of health (such as poverty and social isolation) in the clinical management of blood pressure in Kenya can improve outcomes for patients with diabetes or hypertension.
› Verified 8 days ago
| Entity Name | Community Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538236872 PECOS PAC ID: 5496648123 Enrollment ID: O20040205000697 |
News Archive
The first large-scale, multi-hospital evaluation of an "all or none" federal policy intended to improve outcomes in sepsis patients finds that the guidelines are a wash-;on average they neither helped nor hurt despite significant investments in their implementation, according to an analysis by University of Pittsburgh School of Medicine clinician-scientists of nearly a dozen hospitals in one academic health system.
A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells.
Pioneering technology by scientists at Queen's University Belfast, which is transforming the lives of millions of people in Asia, is now being used to create safer drinking water in the United States.
Pediatric researchers who tested newborn animals with an existing human drug used in adults with diabetes report that this drug, when given very early in life, prevents diabetes from developing in adult animals. If this finding can be repeated in humans, it may become a way to prevent at-risk infants from developing type 2 diabetes.
While cardiovascular disease (CVD) remains the leading cause of death globally, new research led by NYU Grossman School of Medicine and Moi University School of Medicine (Kenya) found that addressing and incorporating social determinants of health (such as poverty and social isolation) in the clinical management of blood pressure in Kenya can improve outcomes for patients with diabetes or hypertension.
› Verified 8 days ago
| Entity Name | Hni Emergency Services Of Ohio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215576087 PECOS PAC ID: 5294162384 Enrollment ID: O20200302002455 |
News Archive
The first large-scale, multi-hospital evaluation of an "all or none" federal policy intended to improve outcomes in sepsis patients finds that the guidelines are a wash-;on average they neither helped nor hurt despite significant investments in their implementation, according to an analysis by University of Pittsburgh School of Medicine clinician-scientists of nearly a dozen hospitals in one academic health system.
A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells.
Pioneering technology by scientists at Queen's University Belfast, which is transforming the lives of millions of people in Asia, is now being used to create safer drinking water in the United States.
Pediatric researchers who tested newborn animals with an existing human drug used in adults with diabetes report that this drug, when given very early in life, prevents diabetes from developing in adult animals. If this finding can be repeated in humans, it may become a way to prevent at-risk infants from developing type 2 diabetes.
While cardiovascular disease (CVD) remains the leading cause of death globally, new research led by NYU Grossman School of Medicine and Moi University School of Medicine (Kenya) found that addressing and incorporating social determinants of health (such as poverty and social isolation) in the clinical management of blood pressure in Kenya can improve outcomes for patients with diabetes or hypertension.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Milton C Wong, MD 36295 Spicebush Ln, Solon, OH 44139-5059 Ph: (440) 248-4589 | Dr Milton C Wong, MD 12301 Snow Rd, Parma, OH 44130-1002 Ph: (216) 362-2185 |
News Archive
The first large-scale, multi-hospital evaluation of an "all or none" federal policy intended to improve outcomes in sepsis patients finds that the guidelines are a wash-;on average they neither helped nor hurt despite significant investments in their implementation, according to an analysis by University of Pittsburgh School of Medicine clinician-scientists of nearly a dozen hospitals in one academic health system.
A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells.
Pioneering technology by scientists at Queen's University Belfast, which is transforming the lives of millions of people in Asia, is now being used to create safer drinking water in the United States.
Pediatric researchers who tested newborn animals with an existing human drug used in adults with diabetes report that this drug, when given very early in life, prevents diabetes from developing in adult animals. If this finding can be repeated in humans, it may become a way to prevent at-risk infants from developing type 2 diabetes.
While cardiovascular disease (CVD) remains the leading cause of death globally, new research led by NYU Grossman School of Medicine and Moi University School of Medicine (Kenya) found that addressing and incorporating social determinants of health (such as poverty and social isolation) in the clinical management of blood pressure in Kenya can improve outcomes for patients with diabetes or hypertension.
› Verified 8 days ago
Fariha Shad, M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12301 Snow Rd, Parma, OH 44130 Phone: 216-524-7377 Fax: 216-265-4459 | |
Dr. Charles Harding King, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5550 Vanture Drive, Cuyahoga County Board Of Health, Parma, OH 44130 Phone: 216-201-2041 | |
Daniela Susoiu Tcaciuc, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6681 Ridge Rd, Suite 400, Parma, OH 44129 Phone: 440-743-2450 Fax: 440-743-2451 | |
Dr. Stephen Joseph Clary, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6087 Ridge Rd, Suite 2, Parma, OH 44129 Phone: 440-884-7272 Fax: 440-884-7972 | |
Dr. Carol Ann D'souza, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12301 Snow Rd, Parma, OH 44130 Phone: 216-621-5600 Fax: 216-479-5554 | |
Dr. Nuzhat Inayat Ashai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12301 Snow Rd, Parma, OH 44130 Phone: 216-621-5600 Fax: 216-265-4459 |